Related Experiment Videos
Antisense oligonucleotides might change the therapeutic landscape for Huntington's disease
Jane S Paulsen1, Christopher S Coffey2
1Department of Neurology, Psychiatry, Psychological and Brain Sciences, University of Iowa, Iowa City, IA 52242, USA; University of Iowa, Iowa City, IA 52242, USA.
The Lancet. Neurology
|September 19, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.
Annals of neurology·2026
Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.
The Lancet. Neurology·2026
Advances in chronic subdural haematoma management: beyond the burr hole.
The Lancet. Neurology·2026
N-Myristoylation: A Central Hub Integrating Tumor Signaling, Metabolism, and Immunity for Precision Therapy.
Medicinal research reviews·2026
Unlocking the hidden DNAzyme repertoire through aptamer-gated exonuclease signal amplification.
Chemical communications (Cambridge, England)·2026
Intranasal administration of spike-specific mRNA-LNP confers more protection than the intramuscular route against SARS-CoV-2.
Iranian journal of basic medical sciences·2026
Evaluation of Posttreatment Eradication Testing Following Helicobacter pylori Therapy.
The Permanente journal·2026
Bridging the Gap: How technology and AI are making clinical trial participation accessible and practical for community physicians.
Journal of the National Medical Association·2026